Health-care companies rose as traders bought into sectors that stand to gain from inflationary trends.
Health-care conglomerate Johnson & Johnson won bankruptcy court approval to keep on hold lawsuits brought by New Mexico and Mississippi that accuse the consumer-health giant of concealing cancer-causing material in its products.
Avenue Therapeutics plunged after the drug developer filed plans for a follow-on offering of warrants and stock.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
10-05-22 1701ET